165 related articles for article (PubMed ID: 12637304)
1. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy.
Alkan A; Sarac K; Kutlu R; Yakinci C; Sigirci A; Aslan M; Baysal T
AJNR Am J Neuroradiol; 2003 Mar; 24(3):501-6. PubMed ID: 12637304
[TBL] [Abstract][Full Text] [Related]
2. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
3. Subacute sclerosing panencephalitis with fulminating course: follow-up magnetic resonance spectroscopy (MRS) findings.
Alkan A; Kutlu R; Sigirci A; Aslan M; Sarac K; Yakinci C
J Child Neurol; 2004 Mar; 19(3):233-8. PubMed ID: 15119488
[TBL] [Abstract][Full Text] [Related]
4. Neuronal loss is an early component of subacute sclerosing panencephalitis.
Yüksel D; Diren B; Ulubay H; Altunbaşak S; Anlar B
Neurology; 2014 Sep; 83(10):938-44. PubMed ID: 25085642
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
6. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.
Achten E; Boon P; Van De Kerckhove T; Caemaert J; De Reuck J; Kunnen M
AJNR Am J Neuroradiol; 1997; 18(6):1131-9. PubMed ID: 9194441
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in three subacute sclerosing panencephalitis patients: correlation with clinical status.
Cakmakci H; Kurul S; Iscan A; Dirik E
Childs Nerv Syst; 2004 Apr; 20(4):216-20. PubMed ID: 14760500
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
9. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in the diagnosis of early-stage subacute sclerosing panencephalitis.
Tekşam M; Cakir B; Ağildere AM
Diagn Interv Radiol; 2006 Jun; 12(2):61-3. PubMed ID: 16752349
[TBL] [Abstract][Full Text] [Related]
11. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
12. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
Reneman L; Majoie CB; Flick H; den Heeten GJ
AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
[TBL] [Abstract][Full Text] [Related]
13. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
Aydin K; Tatli B; Ozkan M; Ciftci K; Unal Z; Sani S; Ozmen M; Caliskan M; Aydinli N; Guven S
Neurology; 2006 Sep; 67(5):911-3. PubMed ID: 16966569
[TBL] [Abstract][Full Text] [Related]
14. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
Simmons A; Smail M; Moore E; Williams SC
Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
[TBL] [Abstract][Full Text] [Related]
15. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
16. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
[TBL] [Abstract][Full Text] [Related]
17. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
18. Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging.
Leite CC; Reed UC; Otaduy MC; Lacerda MT; Costa MO; Ferreira LG; Carvalho MS; Resende MB; Marie SK; Cerri GG
Radiology; 2005 Apr; 235(1):190-6. PubMed ID: 15703311
[TBL] [Abstract][Full Text] [Related]
19. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
